T. Brandt-Sarif

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

Michael Charlton, Gregory T. Everson, Steven L. Flamm et al. · Gastroenterology · 2015 · 799 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

G02 : Ledipasvir/sofosbuvir with ribavirin is safe and efficacious in decompensated and post liver transplantation patients with HCV infection: Preliminary results of the prospective solar 2 trial

Michael Manns, Xavier Forns, Didier Samuel et al. · Journal of Hepatology · 2015 · 68 citations

Medicine, Infectious Diseases, Pharmacotherapy +17

O62 SOFOSBUVIR COMPASSIONATE USE PROGRAM FOR PATIENTS WITH SEVERE RECURRENT HEPATITIS C INCLUDING FIBROSING CHOLESTATIC HEPATITIS FOLLOWING LIVER TRANSPLANTATION

Xavier Forns, M. Prieto, Michael Charlton et al. · Journal of Hepatology · 2014 · 37 citations

Medicine, Internal Medicine, Pharmacotherapy +10

LP13 : Effect of long term viral suppression with sofosbuvir + ribavirin on hepatic venous pressure gradient in HCV-infected patients with cirrhosis and portal hypertension

Nezam H. Afdhal, Gregory T. Everson, José Luís Calleja et al. · Journal of Hepatology · 2015 · 31 citations

Medicine, Infectious Diseases, Pharmacology +17

P0774 : Ledipasvir/sofosbuvir with ribavirin is safe in >600 decompensated and post liver transplantation patients with HCV infection: An integrated safety analysis of the solar 1 and solar 2 trials

Didier Samuel, Michael Manns, Xavier Forns et al. · Journal of Hepatology · 2015 · 19 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17